DR4 MEF, P2, untreated, 1 vial of 1
Order now: dominika@ksiazkiwnauce.pl
CORNING® UNTREATED MICROCARRIERS, 1 VIAL, 10 G |
|||
3772 | CORNING | 10g/pk | 117.6 EUR |
Description: Microcarriers; Corning Microcarriers |
|||
SNL 76/7 mouse fibroblast STO cell line, P12, untreated, 1 vials of 2^106 cells |
|||
ASF-1305 | Applied StemCell | 1 vials of 2 x 10^6 cells | 95.92 EUR |
Description: 6 month |
|||
EZ-LINE Cell culture Dishes Untreated, 35X10mm, PS, Sterile untreated, 500 per case |
|||
SP22146 | Bio Basic | 1CS, 500UNIT | 171 EUR |
Jurkat cell Lysate (untreated) |
|||
2401-100 | Biovision | each | 222 EUR |
4 Well Dish Untreated Sterile With Lid |
|||
267061 | Scientific Laboratory Supplies | PK100 | 1332 EUR |
Rabbit Reticulocyte Lysate System (untreated) |
|||
20-abx800016 | Abbexa |
|
|
75cm U-Shaped Untreated Vent Cap TC Flask |
|||
431464U | Scientific Laboratory Supplies | PK100 | 296.4 EUR |
Human FLL Bone Marrow Mononuclear Cells, Untreated |
|||
ABC-TC3429 | AcceGen | 1 vial | Ask for price |
Description: FLL-Bone Marrow-Mononuclear Cells are obtained by density separation, using Ficoll-Paque to enrich the mononuclear cells. FLL-Bone Marrow-Mononuclear Cells are available in the untreated and relapsed/refractory samples. |
|||
EZ-LINE Cell culture Dishes Untreated, 150X20mm, 120 per case |
|||
SP22260 | Bio Basic | 1CS, 120UNIT | 202.33 EUR |
EZ-LINE Cell culture Dishes Untreated, 150X25mm, 120 per case |
|||
SP22261 | Bio Basic | 1CS, 120UNIT | 228.41 EUR |
Human PV Peripheral Blood Mononuclear Cells (Untreated) |
|||
ABC-TC4051 | AcceGen | 1 vial | Ask for price |
Description: PV Peripheral Blood Mononuclear Cells are enriched by separation using Ficoll-Paque density gradient from the peripheral blood. PV-PBMCs are available in untreated and relapsed/refractory stages. |
|||
DR4 MEF, P3, irradiated, 1 vial of 4^106 cells |
|||
ASF-1013 | Applied StemCell | 1 vial of 4 x 10^6 cells | 107.63 EUR |
Description: 6 month |
|||
DR4 MEF, P3, irradiated, 1 vial of 2^106 cells |
|||
ASF-1015 | Applied StemCell | 1 vial of 2 x 10^6 cells | 87.97 EUR |
Description: 6 month |
|||
Human Multiple Myeloma PB Plasma (Newly Diagnosed/Untreated) |
|||
ABC-TC3952 | AcceGen | 1 vial | Ask for price |
Description: Multiple Myeloma-PB-Plasma is obtained by centrifugation of Multiple Myeloma peripheral blood. Plasma has a diminished number of cells. Multiple Myeloma-PB-Plasma is available in both the newly diagnosed and relapsed/refractory stages. |
|||
EZ-LINE Cell culture Dishes Untreated, 60X15mm, 500 per case |
|||
SP22171 | Bio Basic | 1CS, 500UNIT | 192.59 EUR |
EZ-LINE Cell culture Dishes Untreated, 90X15mm, 500 per case |
|||
SP22201 | Bio Basic | 1CS, 500UNIT | 202.92 EUR |
Human Mantle Cell Lymphoma PB Plasma (Newly Diagnosed/Untreated) |
|||
ABC-TC3891 | AcceGen | 1 vial | Ask for price |
Description: Mantle Cell Lymphoma-Plasma is obtained by centrifugation of blood tissues. Mantle Cell LymphomaPlasma is available in the untreated and relapsed/refractory stages. |
|||
Waldenstrom's Macroglobunemia Bone Marrow Mononuclear Cells, Untreated |
|||
ABC-TC4274 | AcceGen | 1 vial | Ask for price |
Description: Waldenstrom's Macroglobunemia-Bone Marrow-Mononuclear Cells are density separated by Ficoll-Paque to enrich mononuclear cells from the bone marrow. Waldenstrom's Macroglobunemia-Bone Marrow-Mononuclear Cells are available in untreated and relapsed/refractory stages. |
|||
Human Acute Myeloid Leukemia PB Plasma (Newly Diagnosed/Untreated) |
|||
ABC-TC3024 | AcceGen | 1 vial | Ask for price |
Description: Acute Myeloid Leukemia-PB-Plasma is obtained by centrifugation of Acute Myeloid Leukemia peripheral blood. Acute Myeloid Leukemia-PB-plasma has a diminished number of cells and platelets. Acute Myeloid Leukemia plasma is available in the newly diagnosed and relapsed/refractory stages. |
|||
Human Acute Lymphoid Leukemia PB Plasma (Newly Diagnosed/Untreated) |
|||
ABC-TC3011 | AcceGen | 1 vial | Ask for price |
Description: Acute Lymphoid Leukemia-PB-Plasma is obtained by centrifugation of Acute Lymphoid Leukemia peripheral blood. This product has a diminished number of cells. Acute Lymphoid Leukemia-Plasma are available in the newly diagnosed and relapsed/refractory stages. |
|||
Human Chronic Lymphoid Leukemia PB Plasma (Newly Diagnosed/Untreated) |
|||
ABC-TC3350 | AcceGen | 1 vial | Ask for price |
Description: Chronic Lymphoid Leukemia-PB Plasma is obtained by centrifugation of the Chronic Lymphoid Leukemia-PB-Mononuclear Cells. Plasma has a diminished number of cells and platelets. Chronic Lymphoid Leukemia plasma is available in untreated and relapsed/refractory stages. |
|||
Human Multiple Myeloma Bone Marrow Plasma (Newly Diagnosed/Untreated) |
|||
ABC-TC3948 | AcceGen | 1 vial | Ask for price |
Description: Multiple Myeloma-Bone Marrow Plasma is obtained by centrifuging the Multiple Myeloma-bone marrow. The plasma has a diminished number of cells and platelets. Multiple Myeloma-Bone Marrow plasma is available in both the newly diagnosed and relapsed/refractory stages. |
|||
Acute Lymphoid Leukemia PB CD19+ B Cells (Newly Diagnosed/Untreated) |
|||
ABC-TC3008 | AcceGen | 1 vial | Ask for price |
Description: Acute Lymphoid Leukemia-PB-CD19+ B cells are positively isolated from adult Acute Lymphoid Leukemia peripheral blood Mononuclear Cells, using a direct immunomagnetic CD19 MicroBead labeling system. Acute Lymphoid Leukemia-PB-CD19+ B cells are available in the newly diagnosed and relapsed/refractory stages. |
|||
Human Chronic Lymphoid Leukemia Bone Marrow CD19+ B Cells, Untreated |
|||
ABC-TC3338 | AcceGen | 1 vial | Ask for price |
Description: Chronic Lymphoid Leukemia-Bone Marrow-CD19+ B Cells are isolated from Chronic Lymphoid Leukemia bone marrow mononuclear cells using a direct CD19+ system. They are available in untreated or relapsed/refractory stages. |
|||
Human Chronic Lymphoid Leukemia Peripheral Blood CD19+ B Cells, Untreated |
|||
ABC-TC3353 | AcceGen | 1 vial | Ask for price |
Description: Chronic Lymphoid Leukemia-PB-CD19+ B cells are positively isolated from Chronic Lymphoid Leukemia peripheral blood Mononuclear Cells, using a direct immunomagnetic CD19 MicroBeads labeling system. Chronic Lymphoid Leukemia-CD19+ B cells are available in untreated and relapsed/refractory stages. |
|||
Human Mantle Cell Lymphoma Bone Marrow Plasma (Newly Diagnosed/Untreated) |
|||
ABC-TC3887 | AcceGen | 1 vial | Ask for price |
Description: Mantle Cell Lymphoma-Plasma is obtained by centrifugation of blood tissues. Mantle Cell LymphomaPlasma is available in the untreated and relapsed/refractory stages. |
|||
Human Chronic Lymphoid Leukemia Bone Marrow CD19+/CD5+ B Cells, Untreated |
|||
ABC-TC3341 | AcceGen | 1 vial | Ask for price |
Description: Chronic Lymphoid Leukemia-PB-CD19+/CD5+ B cells are isolated from Chronic Lymphoid Leukemia bone marrow mononuclear cells using a direct immunomagnetic CD19+ Micro- Bead labeling system. Available in untreated or relapsed/refractory stages.CD5 co-expression on Bone Marrow-CD19+ B Cells can be used as a strong indicator of Chronic Lymphoid Leukemia infiltration in the bone marrow. In many untreated or lower-staged Chronic Lymphoid Leukemia cases, the co-expression level of CD5 in Bone Marrow-CD19+ cells is significantly lower than the co-expression level within peripheral blood. |
|||
Human Diffuse Large B-Cell Lymphoma PB Plasma (Newly Diagnosed/Untreated) |
|||
ABC-TC3407 | AcceGen | 1 vial | Ask for price |
Description: Diffuse Large B-Cell Lymphoma-PB-Plasma is obtained by centrifugation of peripheral blood tissue. Diffuse Large B-Cell Lymphoma Plasma is available in the untreated and relapsed/refractory stages. |
|||
Human Acute Lymphoid Leukemia Bone Marrow Plasma (Newly Diagnosed/Untreated) |
|||
ABC-TC3006 | AcceGen | 1 vial | Ask for price |
Description: Acute Lymphoid Leukemia Bone Marrow plasma is obtained by centrifugation of the Acute Lymphoid Leukemia-bone marrow. This product has a diminished number of cells and platelets. Acute Lymphoid Leukemia plasma are available in the newly diagnosed and relapsed/refractory stages. |
|||
Human Acute Myeloid Leukemia Bone Marrow Plasma (Newly Diagnosed/Untreated) |
|||
ABC-TC3019 | AcceGen | 1 vial | Ask for price |
Description: Acute Myeloid Leukemia-Bone Marrow Plasma is obtained by centrifugation of the adult Acute Myeloid LeukemiaBone Marrow. Plasma has a diminished number of cells and platelets. Acute Myeloid Leukemia plasma is available in the newly diagnosed and relapsed/refractory stages. |
|||
Human Chronic Lymphoid Leukemia Bone Marrow Plasma (Newly Diagnosed/Untreated) |
|||
ABC-TC3344 | AcceGen | 1 vial | Ask for price |
Description: Chronic Lymphoid Leukemia Bone Marrow-Plasma is obtained by centrifugation of the Chronic Lymphoid Leukemia bone marrow. Plasma has a diminished number of cells and platelets. Chronic Lymphoid Leukemia plasma is available in untreated and relapsed/refractory stages. |
|||
Human Acute Myeloid Leukemia Bone Marrow CD34+ Cells (Newly Diagnosed/Untreated) |
|||
ABC-TC3014 | AcceGen | 1 vial | Ask for price |
Description: Acute Myeloid Leukemia-Bone Marrow-CD34+ cells are selected from adult Acute Myeloid Leukemia-Bone Marrow-Mononuclear Cells. The Bone Marrow-CD34+ stem/progenitor cells are positively isolated using a direct immunomagnetic CD34 MicroBead labeling system. Acute Myeloid LeukemiaCD34+ cells are available in the newly diagnosed and relapsed/refractory stages. |
|||
Human Chronic Lymphoid Leukemia Peripheral Blood CD19+/CD5+ B Cells, Untreated |
|||
ABC-TC3354 | AcceGen | 1 vial | Ask for price |
Description: Chronic Lymphoid Leukemia-PB-CD19+/CD5+ B cells are isolated from Chronic Lymphoid Leukemia peripheral blood mononuclear cells using a direct immunomagnetic CD19+ MicroBead labeling system. Available in untreated or relapsed/refractory stages.The co-expression of CD5 is typically found on cancerous Chronic Lymphoid LeukemiaCD19+ B cells. Current research is underway to identify the Chronic Lymphoid Leukemia clonal origin of Chronic Lymphoid Leukemia from this cell population. Although these cells appear mature in morphology, they are in developmental arrest. Researchers have shown that only 1% of these cells are in an active cycle. CD19+/CD5+ B cells play an important role in production of IgM autoantibodies. |
|||
DR4 MEF, P3, mitomycin-C treated, 1 vial of 4^106 cells |
|||
ASF-1023 | Applied StemCell | 1 vial of 4 x 10^6 cells | 107.63 EUR |
Description: 6 month |
|||
DR4 MEF, P3, mitomycin-C treated, 1 vial of 2^106 cells |
|||
ASF-1025 | Applied StemCell | 1 vial of 2 x 10^6 cells | 87.97 EUR |
Description: 6 month |
|||
Human Multiple Myeloma Bone Marrow Mononuclear Cells (Newly Diagnosed/Untreated) |
|||
ABC-TC3946 | AcceGen | 1 vial | Ask for price |
Description: Multiple Myeloma-Bone Marrow-Mononuclear Cells are isolated by diluting Multiple Myeloma-bone marrow with phosphate-buffered saline and using gradient separation. Multiple Myeloma Bone Marrow-Mononuclear Cells products are available in both the newly diagnosed and relapsed/refractory stages. |